Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: PTO '336 - app.#90/009,457 ..now looking at older documents as well.

IMHO, If the examiner was going to reject claims based on the latest request for reexam, there is no need for him to consider prior art that lies in other disclosures. Unless he is making a case for rejecting the current requests for reexam. So what the examiner is considering might be a clue. I'm going back now to look again myself.

GLTA, Opty

Share
New Message
Please login to post a reply